LYEL Chart
See on advanced chart >
About
Lyell Immunopharma, Inc. was incorporated in Delaware in June 2018. The Company is a T cell reprogramming company dedicated to the mastery of T cells to eradicate solid tumors. The Company is building a multi-modality product pipeline. The Company's primary...
Read More
- HighlightA clinical‑stage T-cell reprogramming company that develops curative cell therapies for solid tumors
- ExchangeNASDAQ
- Listing Date06/17/2021
- Established DateInvalid Date
- Full-time Employees274
- Address201 Haskins Way South San Francisco California 94080
- Tel1-650-6950677
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Biotechnology
